CHINA MEDICAL UNIVERSITY
🇹🇼Taiwan
Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ Carcinoma
Not Applicable
- Conditions
- Gastric Carcinoma
- Interventions
- First Posted Date
- 2020-06-23
- Last Posted Date
- 2020-06-23
- Lead Sponsor
- China Medical University, China
- Target Recruit Count
- 44
- Registration Number
- NCT04443036
- Locations
- 🇨🇳
The First Hospital of China Medical University, Shenyang, Liaoning, China
Characterisation of Gut Microbiota in Patients Undergoing Gastrointestinal Surgery With Postoperative Delirium (GIM-POD)
Not yet recruiting
- Conditions
- Postoperative DeliriumGut Microbiota
- Interventions
- Drug: General anesthetic
- First Posted Date
- 2020-03-20
- Last Posted Date
- 2022-10-25
- Lead Sponsor
- China Medical University, China
- Target Recruit Count
- 30
- Registration Number
- NCT04316910
- Locations
- 🇨🇳
the First Hospital of China Medical University, Shenyang, Liaoning, China
Effect of Esketamine on Postoperative Depression、Gut Microbiota、Bispectral Index Data of Depression Patients Undergoing Breast Cancer Operation (ESPOD-BI)
- First Posted Date
- 2020-03-11
- Last Posted Date
- 2024-07-22
- Lead Sponsor
- China Medical University, China
- Target Recruit Count
- 72
- Registration Number
- NCT04303325
- Locations
- 🇨🇳
the First Hospital of China Medical University, Shenyang, Liaoning, China
Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer
Phase 1
- Conditions
- Advanced Gastric Cancer
- Interventions
- Drug: Albumin-paclitaxel, Apatinib, Camrelizumab
- First Posted Date
- 2020-02-27
- Last Posted Date
- 2020-02-27
- Lead Sponsor
- China Medical University, China
- Target Recruit Count
- 52
- Registration Number
- NCT04286711
- Locations
- 🇨🇳
The First Hospital of China Medical University, Shenyang, Liaoning, China
A Survey of Management of Analgesia, Sedation and Delirium in ICU Patients in China
- Conditions
- Delirium on EmergenceAnalgesiaSeparation
- First Posted Date
- 2020-01-06
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- China Medical University, China
- Target Recruit Count
- 800
- Registration Number
- NCT04217915
- Locations
- 🇨🇳
the first hospital of China Medical University, Shenyang, Liaoning, China
PD-1 Antibody + XELOX in 1st Line Serum A-fetoprotein (AFP)-Elevated Gastric or Gastroesophageal Junction Adenocarcinoma
Phase 2
- Conditions
- Gastric or Gastroesophageal Junction AdenocarcinomaAFP
- Interventions
- Drug: Anti-PD-1 antibodyDrug: XELOX
- First Posted Date
- 2019-09-23
- Last Posted Date
- 2021-04-14
- Lead Sponsor
- China Medical University, China
- Target Recruit Count
- 30
- Registration Number
- NCT04098796
- Locations
- 🇨🇳
Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China
PD-1 Antibody + Apatinib Mesylate in 2+ Line Serum AFP-elevated Gastric Adenocarcinoma
- First Posted Date
- 2019-07-05
- Last Posted Date
- 2021-09-30
- Lead Sponsor
- China Medical University, China
- Target Recruit Count
- 30
- Registration Number
- NCT04006821
- Locations
- 🇨🇳
Cancer Hospital of China Medical University/Liaoning Cancer Hospital &Institute, Shenyang, Liaoning, China
Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer
Phase 1
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- First Posted Date
- 2019-07-05
- Last Posted Date
- 2019-07-05
- Lead Sponsor
- China Medical University, China
- Target Recruit Count
- 54
- Registration Number
- NCT04008511
- Locations
- 🇨🇳
The First Hospital of China Medical University, Shenyang, Liaoning, China
S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites
Phase 2
- Conditions
- Metastatic Gastric Adenocarcinoma
- Interventions
- First Posted Date
- 2019-06-18
- Last Posted Date
- 2019-06-19
- Lead Sponsor
- China Medical University, China
- Target Recruit Count
- 66
- Registration Number
- NCT03990103
- Locations
- 🇨🇳
The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China
Characterisation of Gut Microbiota, Bispectral Index Data and Plasma Kynurenine in Patients Undergoing Video-assisted Thoracic Surgery
Completed
- Conditions
- Lung Cancer
- Interventions
- Drug: General anesthesia
- First Posted Date
- 2019-06-14
- Last Posted Date
- 2020-06-22
- Lead Sponsor
- China Medical University, China
- Target Recruit Count
- 20
- Registration Number
- NCT03985735
- Locations
- 🇨🇳
the First Hospital of China Medical University, Shenyang, Liaoning, China
© Copyright 2025. All Rights Reserved by MedPath